Operating Lease, Liability in USD of NovaBridge Biosciences from Q4 2019 to Q2 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: NovaBridge Biosciences quarterly Operating Lease, Liability history and change rate from Q4 2019 to Q2 2025.
NovaBridge Biosciences Operating Lease, Liability for the quarter ending 30 Jun 2025 was $3.48M.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$3.48M			30 Jun 2025	6-K	06 Oct 2025
Q4 2024	$3.88M	-$2.46M	-38.7%	31 Dec 2024	20-F	03 Apr 2025
Q4 2023	$6.34M	-$1.79M	-22%	31 Dec 2023	20-F	30 Apr 2024
Q4 2022	$8.12M	-$9.52M	-54%	31 Dec 2022	20-F	01 May 2023
Q4 2021	$17.6M	+$15.6M	+747%	31 Dec 2021	20-F	29 Apr 2022
Q4 2020	$2.08M	+$30K	+1.46%	31 Dec 2020	20-F	28 Apr 2021
Q4 2019	$2.05M			31 Dec 2019	20-F	29 Apr 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.